臨床試験は社会からの信頼の上に成り立っており、製薬企業は、結果の透明性を高める努力を続けるべきだ。
Data sharing will pay dividends p.131
As public pressure builds for drug companies to make more results available from clinical trials, the industry should not forget that it relies on collective goodwill to test new therapies.
doi: 10.1038/505131a